Pasaca Capital’s controlling investment in Quantum began with financing ongoing software/App development and sourcing leadership hires, such as the COO from their exclusive network. To secure sustainable revenue and profitability to fund growth, Pasaca facilitated a distribution agreement between Quantum and Innova Medical Group, Inc., a wholly owned subsidiary of Pasaca, to begin incorporating Quantum technology into Innova’s ecosystem of COVID-19 testing solutions.

As a result, Quantum secured substantial funding to move forward on major program initiatives. Pasaca also expedited introductions between Quantum and leaders in medical test and device manufacturing, healthcare, technology, media and telecom, transportation, banking sectors, and across the Asia-Pacific region.